MLA 0.00% 8.5¢ medical australia limited

Ann: Quarterly Report - September 2015, page-5

  1. 1,090 Posts.
    lightbulb Created with Sketch. 25
    I was very impressed with the quarterly. Everything seems to be in place for rapid growth once the Medivet sale is complete.

    My initial investment thesis is still in play though, if management can't finalise a sale soon it's all for nought.
 
watchlist Created with Sketch. Add MLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.